浙江交科(002061.SZ):下屬公司中標2個項目標段
格隆匯6月4日丨浙江交科(002061.SZ)公佈,公司分別於2021年3月23日、5月7日披露了《關於擬中標項目的提示性公吿》,下屬公司浙江交工集團股份有限公司(“浙江交工”)參與部分項目投標,招標人公示了評標結果,浙江交工為第一中標候選人。近日,公司收到項目標段中標通知書。
項目名稱:杭州至寧波國家高速公路(杭紹甬高速)杭州至紹興段越東路互通連接線工程第一合同段標段;中標價:人民幣1,123,351,419元;中標單位:中交第二航務工程局有限公司,浙江交工集團股份有限公司聯合體;
寧德至上饒國家高速公路福建省霞浦至福安段路基土建工程施工A1合同段;中標價:人民幣15億元;中標單位:浙江交工集團股份有限公司。
中標項目符合公司主營業務戰略佈局,能夠鞏固公司在長三角地區市場競爭力和市場佔有率,若上述中標項目順利實施將對公司未來業績將產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.